Tradestie Institutional Equity Comparison Engine

CL vs BUD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BUD Overall Edge

BUD Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Anheuser-Busch INBEV SA/NV (BUD) driven by superior Valuation, Growth & Margin while CL counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, CL trades at 24.3x Forward P/E with 20.7% operating margin (+4.6% YoY revenue) versus BUD at 17.4x Forward P/E and 26.7% operating margin (+9.1% YoY). In options structure, CL sits in SURGE (7th %ile IV; Dealer Gamma Walls on Pro) against BUD sits in UNCLASSIFIED (42nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner BUD
CL 24.3x vs BUD 17.4x Fwd P/E
Growth & Margin Winner BUD
Op Margin 20.7% vs 26.7% ยท YoY +4.6% vs +9.1%
Momentum & Technical Winner CL
1Y +28.8% vs +30.9% ยท 52W Pos 99% vs 92%
Options & Structure Winner CL
SURGE (7th %ile IV) vs UNCLASSIFIED (42nd %ile IV)
CL NYSE
Colgate-Palmolive Company
Perfumes, Cosmetics & Other Toilet Preparations
$101.47
+1.81% 1D
Market Cap $77.8B
1M Return +7.82%
1Y Return +28.79%
Forward P/E 24.3x
Unified AI Score
33.9 / 100 SELL
Tech 42.0 Fund 43.0 Flow 56.0 Mom 31.1
BUD NYSE
Anheuser-Busch INBEV SA/NV
Malt Beverages
$84.55
-0.31% 1D
Market Cap $167.3B
1M Return +2.37%
1Y Return +30.92%
Forward P/E 17.4x
Unified AI Score
34.9 / 100 SELL
Tech 36.0 Fund 35.0 Flow 50.0 Mom 6.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CL +28.79% BUD +30.92% Spread: +2.13 pp (BUD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CL TTM Op. Margin: 20.7% BUD TTM Op. Margin: 26.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CL vs BUD. Trailing 12-month operating profitability (CL 20.7% vs BUD 26.7%) and valuation multiples (CL 24.3x vs BUD 17.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CL (3) vs BUD (7)
Institutional Metric CL BUD Criterion Row Winner
Market Capitalization Scale $77.8B $167.3B Larger Scale BUD
Trailing P/E Ratio Valuation 38.1x 17.3x Lower Multiple BUD
Forward P/E Ratio Valuation 24.3x 17.4x Lower Multiple BUD
Revenue Growth (YoY) Growth +4.6% +9.1% Higher Growth BUD
Operating Margin (TTM) Profitability 20.7% 26.7% Higher Margin BUD
Net Profit Margin Profitability 9.7% 15.4% Higher Margin BUD
Return on Equity (ROE) Capital Efficiency 231.7% 11.4% Higher ROE CL
52-Week Range Position Momentum 99% ($76โ€“$102) 92% ($60โ€“$87) Stronger Trend CL
Beta / 30D Volatility Risk Regime -0.03ฮฒ ยท 30% Vol 0.23ฮฒ ยท 33% Vol Lower Realized Risk CL
Unified Institutional Score Composite Signal 33.9 / 100 (SELL) 34.9 / 100 (SELL) Higher Composite BUD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CL vs BUD Buy Guide
CL SURGE
8d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live CL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BUD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 42nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live BUD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CL nor BUD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.